DE60139574D1 - Kombination von aktiviertem factor viia und fibrinogen und verwendung zur behandlung von blutung - Google Patents

Kombination von aktiviertem factor viia und fibrinogen und verwendung zur behandlung von blutung

Info

Publication number
DE60139574D1
DE60139574D1 DE60139574T DE60139574T DE60139574D1 DE 60139574 D1 DE60139574 D1 DE 60139574D1 DE 60139574 T DE60139574 T DE 60139574T DE 60139574 T DE60139574 T DE 60139574T DE 60139574 D1 DE60139574 D1 DE 60139574D1
Authority
DE
Germany
Prior art keywords
fibrinogen
combination
factor viia
bleeding
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60139574T
Other languages
English (en)
Inventor
John R Hess
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Army Medical Research and Materiel Command USAMRMC
Original Assignee
US Army Medical Research and Materiel Command USAMRMC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Army Medical Research and Materiel Command USAMRMC filed Critical US Army Medical Research and Materiel Command USAMRMC
Application granted granted Critical
Publication of DE60139574D1 publication Critical patent/DE60139574D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4846—Factor VII (3.4.21.21); Factor IX (3.4.21.22); Factor Xa (3.4.21.6); Factor XI (3.4.21.27); Factor XII (3.4.21.38)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60139574T 2001-01-10 2001-01-10 Kombination von aktiviertem factor viia und fibrinogen und verwendung zur behandlung von blutung Expired - Lifetime DE60139574D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2001/000725 WO2002055102A1 (en) 2001-01-10 2001-01-10 Compositions for treatment of hemorrhaging with activated factor viia in combination with fibrinogen

Publications (1)

Publication Number Publication Date
DE60139574D1 true DE60139574D1 (de) 2009-09-24

Family

ID=21742239

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60139574T Expired - Lifetime DE60139574D1 (de) 2001-01-10 2001-01-10 Kombination von aktiviertem factor viia und fibrinogen und verwendung zur behandlung von blutung

Country Status (8)

Country Link
EP (1) EP1351705B1 (de)
AT (1) ATE439142T1 (de)
AU (1) AU2001227771B2 (de)
CA (1) CA2437024A1 (de)
DE (1) DE60139574D1 (de)
DK (1) DK1351705T3 (de)
ES (1) ES2331461T3 (de)
WO (1) WO2002055102A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2894831B1 (fr) * 2005-12-16 2008-02-15 Lab Francais Du Fractionnement Colle biologique exempte de thrombine et son utilisation comme medicament.
FR3026644B1 (fr) * 2014-10-07 2018-01-05 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Colle biologique et son utilisation comme medicament
IL247821A0 (en) 2016-09-14 2017-01-31 Omrix Biopharmaceuticals Ltd Adhesive preparations and their use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374617A (en) * 1992-05-13 1994-12-20 Oklahoma Medical Research Foundation Treatment of bleeding with modified tissue factor in combination with FVIIa
EP0885020A1 (de) * 1996-02-20 1998-12-23 Cohesion Corporation Verbindungen zum gewebeverschluss und methoden zu deren gebrauch
SI0796623T1 (en) * 1996-03-20 2005-10-31 Baxter Aktiengesellschaft Pharmaceutical preparation for the treatment of blood coagulation disorders

Also Published As

Publication number Publication date
AU2001227771B2 (en) 2007-05-31
EP1351705A1 (de) 2003-10-15
CA2437024A1 (en) 2002-07-18
WO2002055102A1 (en) 2002-07-18
DK1351705T3 (da) 2009-11-02
ES2331461T3 (es) 2010-01-05
ATE439142T1 (de) 2009-08-15
EP1351705B1 (de) 2009-08-12

Similar Documents

Publication Publication Date Title
Yi et al. The use of pneumatic tourniquet in total knee arthroplasty: a meta-analysis
Sterling et al. Hemostasis in burn surgery—a review
de Chalain Exploring the use of the medicinal leech: a clinical risk-benefit analysis
Bilgili et al. Hemostatic efficacy of Ankaferd Blood Stopper® in a swine bleeding model
Toro et al. TachoSil use in abdominal surgery: a review
ATE292979T1 (de) Verwendung von aktiviertem protein-c zur behandlung überschiessender blutgerinnung bei sepsis
CY1113705T1 (el) Μεθοδοι για τη θεραπεια αιμορραγικων διαταραχων με τη χρηση θειωμενων πολυσακχαριτων
MX2009001323A (es) Aposito solido para tratar tejido herido.
ATE505488T1 (de) Modulator von coagulationskaskaden und fibrinolytischen kaskaden
Jackson et al. Hemostatic efficacy of fibrin sealant (human) on expanded poly-tetrafluoroethylene carotid patch angioplasty: a randomized clinical trial
DE60139574D1 (de) Kombination von aktiviertem factor viia und fibrinogen und verwendung zur behandlung von blutung
Petratos et al. Transforming growth factor‐β2 (TGF‐β2) reverses the inhibitory effects of fibrin sealant on cutaneous wound repair in the pig
Velyvis Gelatin matrix use reduces postoperative bleeding after total knee arthroplasty
Stevenson et al. The superficial inferior epigastric artery flap for coverage of hand and forearm defects
DE69227042D1 (de) Verfahren und zusammensetzungen zur verminderung von blutverlust
Irvine et al. Hand venous hypertension complicating arterio‐venous fistula construction for haemodialysis
DE60040236D1 (de) Medizinische zusammensetzungen zur behandlung und vorbeugung von auf abnormaler blutgerinnung basierenden erkrankungen
Rothwell et al. ε-Amino caproic acid additive decreases fibrin bandage performance in a swine arterial bleeding model
Sussman et al. Arteriovenous fistula for self-treatment of hemophilia
RU2381758C2 (ru) Устройство для проведения ампутации конечности
Kuppusamy et al. Hemostatic agents-A review.
Spotnitz Tissue adhesives: science, products, and clinical use
TH76071A (th) สารผสมสำหรับการบำบัดรักษาการตกเลือด ที่มีแฟกเตอร์ viia ที่ถูกกระตุ้นในการรวมกันด้วย ไฟบริโนเจน และวิธีการใช้สารนี้
Reddy et al. Forearm compartment syndrome following puncture of haemodialysis access fistula
Ghoz et al. Suppl 2: M10: Use of a Thrombin Fibrin Sealant in Reducing Blood Loss in Revision Hip Arthroplasty

Legal Events

Date Code Title Description
8364 No opposition during term of opposition